Author:
Guichard S,Terret C,Hennebelle I,Lochon I,Chevreau P,Frétigny E,Selves J,Chatelut E,Bugat R,Canal P
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Benedetti, P., Fiorani, P., Capuani, L. & Wang, J. C. (1993). Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res 53: 4343–4348.
2. Bradford, M. M. (1976). A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
3. Bronstein, I. B., Vorobyev, S., Timofeev, A., Jolles, C. J., Alder, S. I. & Holden, J. A. (1996). Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies. Oncol Res 8: 17–25.
4. Codegoni, A. M., Castagna, S., Mangioni, C., Scovassi, A. I., Broggini, M. & D’Incalci, M. (1998). DNA-topoisomerase I activity and content in epithelial ovarian cancer. Ann Oncol 9: 313–319.
5. Cornarotti, M., Capranico, G., Bohm, S., Oriana, S., Spatti, G. B., Mariani, L., Ballabio, G. & Zunino, F. (1996). Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Int J Cancer 67: 479–484.
Cited by
124 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献